Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients.
Rosenson, Robert S
Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. [electronic resource] - Journal of the American College of Cardiology Sep 2010 - 1079-88 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
1558-3597
10.1016/j.jacc.2010.06.015 doi
Acetates--administration & dosage
Acute Coronary Syndrome--diagnosis
Aged
Atorvastatin
Biomarkers--blood
C-Reactive Protein--analysis
Cholesterol, LDL--analysis
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Heptanoic Acids--administration & dosage
Humans
Indoles--administration & dosage
Keto Acids
Logistic Models
Male
Middle Aged
Phospholipases A2, Secretory--blood
Prospective Studies
Pyrroles--administration & dosage
Reference Values
Treatment Outcome
Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. [electronic resource] - Journal of the American College of Cardiology Sep 2010 - 1079-88 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
1558-3597
10.1016/j.jacc.2010.06.015 doi
Acetates--administration & dosage
Acute Coronary Syndrome--diagnosis
Aged
Atorvastatin
Biomarkers--blood
C-Reactive Protein--analysis
Cholesterol, LDL--analysis
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Female
Follow-Up Studies
Heptanoic Acids--administration & dosage
Humans
Indoles--administration & dosage
Keto Acids
Logistic Models
Male
Middle Aged
Phospholipases A2, Secretory--blood
Prospective Studies
Pyrroles--administration & dosage
Reference Values
Treatment Outcome